Taiwan - Delayed Quote TWD

Tanvex BioPharma, Inc. (6541.TW)

48.00 +0.50 (+1.05%)
At close: April 26 at 1:30 PM GMT+8

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS -3.5-3.57----

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2025)
No. of Analysts 111--
Avg. Estimate 133M203M61.41M--
Low Estimate 133M203M635M--
High Estimate 133M203M635M--
Year Ago Sales ----22.4M61.41M
Sales Growth (year/est) ----174.10%--

Earnings History

CURRENCY IN USD 6/30/2021 9/30/2021 12/31/2022 3/31/2023
EPS Est. -4.68-4.48-2.66-2.2
EPS Actual -3.5-3.57-3.9-5.11
Difference 1.180.91-1.24-2.91
Surprise % 25.20%20.30%-46.60%-132.30%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2025)
Current Estimate 0000
7 Days Ago -1.9-1.4-6.730
30 Days Ago -1.9-1.4-6.730
60 Days Ago -1.9-1.4-6.730
90 Days Ago -1.9-1.4-6.730

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD 6541.TWIndustrySectorS&P 500
Current Qtr. ------5.40%
Next Qtr. ------10.90%
Current Year ------4.50%
Next Year ------13.10%
Next 5 Years (per annum) ------10.94%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

Earnings

Consensus EPS
 

Related Tickers